183 related articles for article (PubMed ID: 20829881)
1. SATB2 augments ΔNp63α in head and neck squamous cell carcinoma.
Chung J; Lau J; Cheng LS; Grant RI; Robinson F; Ketela T; Reis PP; Roche O; Kamel-Reid S; Moffat J; Ohh M; Perez-Ordonez B; Kaplan DR; Irwin MS
EMBO Rep; 2010 Oct; 11(10):777-83. PubMed ID: 20829881
[TBL] [Abstract][Full Text] [Related]
2. TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer.
Lu H; Yang X; Duggal P; Allen CT; Yan B; Cohen J; Nottingham L; Romano RA; Sinha S; King KE; Weinberg WC; Chen Z; Van Waes C
Cancer Res; 2011 Nov; 71(21):6867-77. PubMed ID: 21933882
[TBL] [Abstract][Full Text] [Related]
3. Phospho-DeltaNp63alpha/NF-Y protein complex transcriptionally regulates DDIT3 expression in squamous cell carcinoma cells upon cisplatin exposure.
Huang Y; Chuang AY; Romano RA; Liégeois NJ; Sinha S; Trink B; Ratovitski E; Sidransky D
Cell Cycle; 2010 Jan; 9(2):328-38. PubMed ID: 20023394
[TBL] [Abstract][Full Text] [Related]
4. Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance.
Huang Y; Bell LN; Okamura J; Kim MS; Mohney RP; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2012 Oct; 11(20):3810-27. PubMed ID: 22951905
[TBL] [Abstract][Full Text] [Related]
5. ΔNp63α utilizes multiple mechanisms to repress transcription in squamous cell carcinoma cells.
Gallant-Behm CL; Espinosa JM
Cell Cycle; 2013 Feb; 12(3):409-16. PubMed ID: 23324337
[TBL] [Abstract][Full Text] [Related]
6. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
[TBL] [Abstract][Full Text] [Related]
8. TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
Si H; Lu H; Yang X; Mattox A; Jang M; Bian Y; Sano E; Viadiu H; Yan B; Yau C; Ng S; Lee SK; Romano RA; Davis S; Walker RL; Xiao W; Sun H; Wei L; Sinha S; Benz CC; Stuart JM; Meltzer PS; Van Waes C; Chen Z
Oncogene; 2016 Nov; 35(44):5781-5794. PubMed ID: 27132513
[TBL] [Abstract][Full Text] [Related]
9. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis.
Rocco JW; Leong CO; Kuperwasser N; DeYoung MP; Ellisen LW
Cancer Cell; 2006 Jan; 9(1):45-56. PubMed ID: 16413471
[TBL] [Abstract][Full Text] [Related]
10. DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance.
Danilov AV; Neupane D; Nagaraja AS; Feofanova EV; Humphries LA; DiRenzo J; Korc M
PLoS One; 2011; 6(10):e26815. PubMed ID: 22053213
[TBL] [Abstract][Full Text] [Related]
11. RACK1 and stratifin target DeltaNp63alpha for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage.
Fomenkov A; Zangen R; Huang YP; Osada M; Guo Z; Fomenkov T; Trink B; Sidransky D; Ratovitski EA
Cell Cycle; 2004 Oct; 3(10):1285-95. PubMed ID: 15467455
[TBL] [Abstract][Full Text] [Related]
12. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer.
Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C
Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016
[TBL] [Abstract][Full Text] [Related]
13. HSF1 activates the FOXO3a-ΔNp63α-CDK4 axis to promote head and neck squamous cell carcinoma cell proliferation and tumour growth.
Wang Y; Zhu Q; Guo S; Ao J; Zhang W; Fei J; Yu S; Niu M; Zhang Y; Sherman MY; Xiao ZJ; Yi Y
FEBS Lett; 2023 Apr; 597(8):1125-1137. PubMed ID: 36700826
[TBL] [Abstract][Full Text] [Related]
14. Regulation of ΔNp63α by NFκΒ.
Sen T; Chang X; Sidransky D; Chatterjee A
Cell Cycle; 2010 Dec; 9(24):4841-7. PubMed ID: 21088498
[TBL] [Abstract][Full Text] [Related]
15. deltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes.
King KE; Ponnamperuma RM; Yamashita T; Tokino T; Lee LA; Young MF; Weinberg WC
Oncogene; 2003 Jun; 22(23):3635-44. PubMed ID: 12789272
[TBL] [Abstract][Full Text] [Related]
16. DeltaNp63alpha-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma.
Higashikawa K; Yoneda S; Tobiume K; Saitoh M; Taki M; Mitani Y; Shigeishi H; Ono S; Kamata N
Int J Cancer; 2009 Jun; 124(12):2837-44. PubMed ID: 19267405
[TBL] [Abstract][Full Text] [Related]
17. DeltaNp63alpha confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulation.
Sen T; Sen N; Brait M; Begum S; Chatterjee A; Hoque MO; Ratovitski E; Sidransky D
Cancer Res; 2011 Feb; 71(3):1167-76. PubMed ID: 21266360
[TBL] [Abstract][Full Text] [Related]
18. Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
Huang Y; Jeong JS; Okamura J; Sook-Kim M; Zhu H; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2012 Jun; 11(12):2367-79. PubMed ID: 22672905
[TBL] [Abstract][Full Text] [Related]
19. ΔNp63α promotes Bortezomib resistance via the CYGB-ROS axis in head and neck squamous cell carcinoma.
Zhou P; Zhang C; Song X; Zhang D; Zhu M; Zheng H
Cell Death Dis; 2022 Apr; 13(4):327. PubMed ID: 35397613
[TBL] [Abstract][Full Text] [Related]
20. Phospho-ΔNp63α/Rpn13-dependent regulation of LKB1 degradation modulates autophagy in cancer cells.
Huang Y; Ratovitski EA
Aging (Albany NY); 2010 Dec; 2(12):959-68. PubMed ID: 21191146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
